Is scintigraphic double-track appearance a sign of severe acute episodes of ulcerative colitis?

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 3, 2004, Pages 221-225

  Morelec, Isabelle ^a   Nancey, Stéphane ^a   Roman, Sabine ^a   Rocca, Pierre ^a   Potier, Pascal ^a   François, Yves ^a   Pellet, Olivier ^a   Vignal, Jacques ^a   Bonmartin, Alain ^a   Descos, Louis ^a   Flourié, Bernard ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADOLESCENT; ADULT; AGED; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL TRACT SCINTISCANNING; GRANULOCYTE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; REVIEW; SIGMOIDOSCOPY; ULCERATIVE COLITIS;

EID: 11144354514     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(04)94887-7     Document Type: Article

References (30)

1. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955;2:1041-8.
2. Chapman RW, Selby WS, Jewell DP. Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut 1986;27:1210-2.
3. Buckell NA, Williams GT, Bartram CI, Lennard-Jones JE. Depth of ulceration in acute colitis: correlation with outcome and clinical and radiologic features. Gastroenterology 1980;79:19-25.
4. Alemayehu G, Jamerot G. Colonoscopy during an attack of severe ulcerative colitis is a safe procedure and of great value in clinical decision making. Am J Gastroenterol 1991;86:187-90.
5. Carbonnel F, Lavergne A, Lemann M, Bitoun A, Valleur P, Hautefeuille P, et al. Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci 1994;39:1550-7.
6. Danovitch SH. Fulminant colitis and toxic megacolon. Gastroenterol Clin North Am 1989;18:73-82.
7. Harber GB. Role of endoscopy in inflammatory bowel disease. Dig Dis Sci 1987:32 (suppl 12):16S-7S.
8. Williams CB, Waye JD. Colonoscopy in inflammatory bowel disease. In: Schiller KF, ed. Clinical Gastroenterology. London: Saunders; 1978:701-17.
9. Shanahan F, Targan S, Anton P, Duerr R. Colonoscopy during an attack of severe ulcerative colitis. Am J Gastroenterol 1991;86:1278.
10. Bretagne JF, Moisan A, Darnault P. Epreuves isotopiques au cours des maladies inflammatoires de l'intestin. In: Modigliani R, ed. Maladies inflammatoires de l'intestin. Progrès en hépato-gastro-enté rologie. Paris: Doin; 1988:91-103.
11. Sciarretta G, Fumo A, Mazzoni M, Basile C, Malaguti P. Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: diagnostic and clinical relevance. Gut 1993;34: 1364-9.
12. Weldon MJ, Masoomi AM, Britten AJ, Gane J, Finlayson CJ, Joseph AE, et al. Quantification of inflammatory bowel disease activity using technetium-99m HMPAO labelled leucocyte single photon emission computerised tomography (SPECT). Gut 1995;36:243-50.
13. Giaffer MH. Labelled leucocyte scintigraphy in inflammatory bowel disease: clinical applications. Gut 1996;38:1-5.
14. Kolkman JJ, Falke TH, Roos JC, Van Dijk DH, Bannink IM, Den Hollander W, et al. Computed tomography and granulocyte scintigraphy in active inflammatory bowel disease. Comparison with endoscopy and operative findings. Dig Dis Sci 1996;41:641-50.
15. Guimbaud R, Beades E, Chauvelot-Moachon L, Quartier G, Gaudric M, Bertrand V, et al. Technetium Tc 99m hexamethyl propylene amine oxine leukocyte scintigraphy in patients with ulcerative colitis: correlation with clinical, biologic, endoscopic, and pathologic intensity, and local release of interleukin 8. Gastrointest Endosc 1998;48:491-6.
16. Bernades P, Hecketsweiler P, Benozio M, Descos L, Geffroy Y, Hemet J, et al. Proposition d'un système de critères pour le diagnostic des entérocolites inflammatoires cryptogénétiques. Gastroenterol Clin Biol 1978;2:1047-54.
17. Peters AM, Danpure HJ, Osman S, Hawker RJ, Henderson BL, Hodgson HJ, et al. Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation. Lancet 1986;2:946-9.
18. Moisan A, Lecloirec J, Herry JY. Marquage des plaquettes et des granulocytes par L'oxine-indium 111. J Biophys Med Nucl 1983;7: 113-5.
19. 99mTc-HMPAO. Med Nucl 1994;18: 185-9.
20. Scholmerich J, Schmidt E, Schumichen C, Billmann P, Schmidt H, Gerok W. Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label. Gastroenterology 1988;95:1287-93.
21. 99mTc dans le bilan d'activité et d'extension des entérocolites cryptogé nétiques. Med Nucl 1993;17:108-14.
22. Lennard-Jones JE, Ritchie JK, Hilder W, Spicer CC. Assessment of severity in colitis: a preliminary study. Gut 1975;16:579-84.
23. Block GE, Moossa AR, Simonowitz D, Hassan SZ. Emergency colectomy for inflammatory bowel disease. Surgery 1977;82:531-6.
24. Surawicz CM. Diagnosing colitis. Biopsy is best. Gastroenterology 1987;92:538-40.
25. Nostrant TT, Kumar NB, Appelman HD. Histopathology differentiates acute self-limited colitis from ulcerative colitis. Gastroenterology 1987;92:318-28.
26. Beades E, Devaux JY, Guimbaud R, Kerrou K, Morelec I, Sogni P, et al. Scintigraphic pathognomonic aspect in severe acute attack of ulcerative colitis (abstract). Eur J Nucl Med 1994;21:751.
27. Lantto E, Jarvi K, Krekela I, Lantto T, Taavitsainen M, Vedenkangas H, et al. Technetium-99m hexamethyl propylene amine oxine leucocytes in the assessment of disease activity in inflammatory bowel disease. Eur J Nucl Med 1992;19:14-8.
28. Weldon MJ. Assessment of inflammatory bowel disease activity using 99mTc-HMPAO single-photon emission computerized tomography imaging. Scand J Gastroenterol Suppl 1994;203:61-8.
29. Spinelli F, Milella M, Sara R, Banfi F, Vigorelli R, Possa M, et al. The 99mTc-HMPAO leukocyte scan: an alternative to radiology and endoscopy in evaluating the extent and the activity of inflammatory bowel disease. J Nucl Biol Med 1991;35:82-7.
30. Almer S, Franzen L, Peters AM, Tjadermo M, Ekberg S, Granerus G, et al. Do technetium-99m hexamethylpropylene amine oxime-labeled leukocytes truly reflect the mucosal inflammation in patients with ulcerative colitis? Scand J Gastroenterol 1992;27:1031-8.